Evolution of therapy for locally advanced rectal cancer
Journal of Surgical Oncology · 2024
DOI: 10.1002/jso.27531 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Nicole J Altomare und 1 weiteren Autor:innen. Beteiligte Einrichtung: McGaw Medical Center of Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Rectal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Rectal cancer is a prevalent disease worldwide. The standard treatment of locally advanced rectal cancer (LARC) is preoperative chemoradiotherapy followed by surgery and adjuvant systemic chemotherapy. Studies have been done to determine the best sequence of treatments to improve survival, cure rate and long term toxicity profile. In this paper, we will review the literature regarding the evolution of LARC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- McGaw Medical Center of Northwestern University, Chicago, Illinois, USA.
- The Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.
Zitieren
APA
Altomare, N. J., & Mulcahy, M. F. (2024). Evolution of therapy for locally advanced rectal cancer. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27531
Vancouver
Altomare NJ, Mulcahy MF. Evolution of therapy for locally advanced rectal cancer. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27531
BibTeX
@article{Altomare2024,
author = {Altomare, Nicole J and Mulcahy, Mary F},
title = {Evolution of therapy for locally advanced rectal cancer},
journal = {Journal of Surgical Oncology},
year = {2024},
doi = {10.1002/jso.27531}
}
EUVIMED